RTTNews | Oct 26, 2021 10:30AM EDT

10:30 Tuesday, October 26, 2021 (RTTNews.com) - Shares of Roivant Sciences Ltd. (ROIV) are gaining over 20% on Tuesday morning. ROIV is currently trading at $8.51, up $1.47 or 20.88%, on the Nasdaq.

Roivant Sciences, a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, and psoriasis.

Jefferies has initiated coverage on Roivant Sciences with buy rating and $10 price target. Cowen also has initiated coverage on the company with outperform rating.

Read the original article on RTTNews ( https://www.rttnews.com/3235660/why-is-roivant-sciences-stock-rising-above-20.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved